Crohn's Disease

FDA guidance machine churns out 8 new documents in less than a week
Endpoints
Mon, 05/2/22 - 06:17 pm
FDA
regulatory
ulcerative colitis
Crohn's Disease
cancer
clinical trials
J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data
Fierce Pharma
Mon, 02/21/22 - 10:37 am
JNJ
Janssen
Tremfya
Crohn's Disease
Takeda bags Japanese approval for Crohn’s cell therapy Alofisel
Pharmaforum
Mon, 09/27/21 - 10:49 am
Takeda
Alofisel
cell therapy
Crohn's Disease
Japan
AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq
Fierce Pharma
Wed, 05/26/21 - 12:05 pm
AbbVie
Humira
drug pricing
patents
immunology
Skyrizi
Rinvoq
clinical trials
Crohn's Disease
atopic dermatitis
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals
Endpoints
Mon, 10/12/20 - 10:28 am
Eli Lilly
mirikizumab
Crohn's Disease
clinical trials
Boehringer Ingelheim adds second AI partner in a month
Endpoints
Wed, 05/6/20 - 12:14 pm
Boehringer Ingelheim
artificial intelligence
BERG
Bayesian AI
biomarkers
Crohn's Disease
inflammatory bowel disease
Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis
Pharmaceutical Business Review
Mon, 02/17/20 - 10:20 am
Celltrion
clinical trials
CT-P13
Crohn's Disease
ulcerative colitis
Janssen trials ultrasound-guided approach to treating Crohn’s
Pharmaforum
Fri, 02/14/20 - 10:41 am
JNJ
Janssen
guided ultrasound
Stelara
Crohn's Disease
Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease
Endpoints
Wed, 11/13/19 - 11:22 pm
Takeda
Finch Therapeutics
microbiome
Crohn's Disease
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Endpoints
Wed, 10/23/19 - 10:12 am
Provention Bio
JNJ
Crohn's Disease
clinical trials
PRV-6527
$60M B round to propel Landos through Phase II IBD trials
BioCentury
Wed, 08/14/19 - 11:07 am
Landos Biopharma
clinical trials
ulcerative colitis
Crohn's Disease
BT-11
Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease
Pharmaceutical Business Review
Wed, 05/22/19 - 09:55 am
Eli Lilly
Crohn's Disease
mirikizumab
Takeda is ready to auction off a PhIII favorite at Shire to clear the last hurdles to a $62B buyout
Enpoints
Sun, 10/28/18 - 07:47 pm
Takeda
Shire
inflammatory bowel disease
IBD
ulcerative colitis
Crohn's Disease
M&A
SHP647
Microbiome Biotech Enterome and Takeda sign Crohn's Deal Worth Up To $600 Million+
CP Wire
Thu, 10/25/18 - 11:27 pm
Enterome
Takeda
Crohn's Disease
EB8018
Microbiome Biotech Enterome and Takeda sign Crohn's Deal Worth Up To $600 Million+
Thu, 10/25/18 - 12:41 pm
Enterome
Takeda
Crohn's Disease
EB8018
Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Wed, 10/24/18 - 02:43 pm
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
Stelara Shines in Three Year Crohn's Disease Study
Wed, 10/24/18 - 10:05 am
Jannsen
JNJ
Stelara
Crohn's Disease
Arena 3 for 3 as Crohn’s drug meets proof-of-concept test
Fierce Biotech
Tue, 09/25/18 - 10:01 am
Arena Pharmaceuticals
olorinab
Crohn's Disease
RedHill’s RHB-104 hits primary endpoint in Crohn’s phase 3
Fierce Biotech
Mon, 07/30/18 - 11:23 am
Redhill Biopharma
clinical trials
Crohn's Disease
RHB-104

Pages